RIMKLA Antikörper (AA 19-391)

Produktnummer ABIN7600414

Der Kaninchen Polyklonal Anti-RIMKLA-Antikörper wurde für WB und ELISA validiert. Er ist geeignet, RIMKLA in Proben von Human zu detektieren.

Kurzübersicht für RIMKLA Antikörper (AA 19-391) (ABIN7600414)

Target: RIMKLA (Ribosomal Modification Protein RimK-Like Family Member A (RIMKLA))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser RIMKLA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-RIMKLA Antikörper

Bindungsspezifität: AA 19-391

Verwendungszweck: Anti-RIMKLA Antibody Picoband®

Kreuzreaktivität (Details): No cross-reactivity with other proteins.

Produktmerkmale: Anti-RIMKLA Antibody Picoband® (ABIN7600414). Tested in ELISA, WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

Aufreinigung: Immunogen affinity purified.

Immunogen: E.coli-derived human RIMKLA recombinant protein (Position: Q19-K391).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western blot, 0.25-0.5 μg/mL, Human
ELISA, 0.1-0.5 μg/mL, -
1. Collard, F., Stroobant, V., Lamosa, P., Kapanda, C. N., Lambert, D. M., Muccioli, G. G., Poupaert, J. H., Opperdoes, F., Van Schaftingen, E. Molecular identification of N-acetylaspartylglutamate synthase and beta-citrylglutamate synthase. J. Biol. Chem. 285: 29826-29833, 2010. 2. Gross, M. B. Personal Communication. Baltimore, Md. 7/13/2020. 3. Lodder-Gadaczek, J., Becker, I., Gieselmann, V., Wang-Eckhardt, L., Eckhardt, M. N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate. J. Biol. Chem. 286: 16693-16706, 2011.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

Konzentration: 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.

Details zu RIMKLA

Target: RIMKLA (Ribosomal Modification Protein RimK-Like Family Member A (RIMKLA))

Andere Bezeichnung: RIMKLA

Hintergrund:

Synonyms: Solute carrier family 2, facilitated glucose transporter member 6, Glucose transporter type 6, GLUT-6, Glucose transporter type 9, GLUT-9, SLC2A6, GLUT9

Tissue Specificity: Highly expressed in brain, spleen and peripheral blood leukocytes.

Background: Predicted to enable N-acetyl-L-aspartate-L-glutamate ligase activity. Predicted to be involved in glutamine family amino acid metabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm.

Molekulargewicht: 43 kDa

Gen-ID: 284716